Publication | Open Access

Case of slowly progressive type 1 diabetes mellitus with drastically reduced insulin secretory capacity after immune checkpoint inhibitor treatment for advanced renal cell carcinoma

UrologyGenitourinary CancerDiabetesImmunologyInsulin Secretory CapacityDiabetic Kidney DiseaseImmune Checkpoint InhibitorProgressive Type 1ImmunotherapyMedicineTumor Microenvironment